Validation of an automated system for glaucoma screening that runs offline on a smartphone-based fundus camera

Remidio Innovative Solutions0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Participants older than 18 years of age who can provide a written informed consent

•1.Participants unwilling to sign the informed consent
•2.Patient with acute or sudden vision loss
•3.Patient deemed to have narrow angles on gonioscopy and cannot be dilated
•4.Co-existing retinal/disc pathologies precluding view of disc
•5.Significant media opacity precluding adequate view of the disc
•6.Participant has a condition that, in the opinion of the investigator, would preclude participation in the study (e.g., uncontrolled intraocular pressure, active eye infection, <3months post glaucoma filtering surgery, unstable medical status including blood pressure or glycemic control etc).
•7.Participant is contraindicated for imaging by fundus imaging systems used in the study:
•a.Participant is hypersensitive to light
•b.Participant recently underwent photodynamic therapy (PDT)
•c.Participant is photosensitive or is consuming medication that causes photosensitivity.

发起方

Remidio Innovative Solutions